Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Plasma cell 1Other hematologic neoplasm 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 9481Triple Negative Breast Neoplasms 635Neoplasms 413Lung Neoplasms 342Prostatic Neoplasms 321Ovarian Neoplasms 299Colorectal Neoplasms 289Neoplasm Metastasis 280Motor Activity 267Carcinoma, Intraductal, Noninfiltrating 231Colonic Neoplasms 193Breast Neoplasms, Male 172Lymphedema 170Melanoma 158Pancreatic Neoplasms 152Breast Carcinoma In Situ 151Carcinoma, Non-Small-Cell Lung 149Uterine Cervical Neoplasms 144Fatigue 140Head and Neck Neoplasms 132Pain 122Breast Cancer Female 122Brain Neoplasms 118Stomach Neoplasms 117Sarcoma 106Depression 105Breast Cancer Lymphedema 101Anxiety Disorders 101Lymphoma 96Cardiotoxicity 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Behavioral Symptoms × Breast × Clear all
NCT04379414 2025-12-09

YES

Dana-Farber Cancer Institute

Phase NA Active not recruiting
400 enrolled
Breast

Behavioral Symptoms, Breast Neoplasms

NCT02043184 2017-06-07

Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR

Michigan State University

Phase NA Completed
322 enrolled
BreastDermatologicGastrointestinalGenitourinaryOther hematologic neoplasm

Behavioral Symptoms, Breast Neoplasms, Depression, Leukemia, Melanoma, Neoplasms, Patient Acceptance of Health Care, Prostatic Neoplasms, Colorectal Neoplasms, Neurobehavioral Manifestations, Medication Adherence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡